Marked elevation of plasma procalcitonin levels in patients with diabetic ketoacidosis: A possible useful diagnostic biomarker - 20/11/20
Doi : 10.1016/j.diabet.2019.05.006
T. Anno a, ⁎ 
, R. Shigemoto a, F. Kawasaki a, S. Irie a, N. Miyashita a, K. Kaku a, H. Kaneto b
, R. Shigemoto a, F. Kawasaki a, S. Irie a, N. Miyashita a, K. Kaku a, H. Kaneto b a Department of General Internal Medicine 1, Kawasaki Medical School, Okayama 700-8505, Japan
b Department of Diabetes, Metabolism and Endocrinology, Kawasaki Medical School, Kurashiki 701-0192, Japan
⁎Corresponding author at: Department of General Internal Medicine 1, Kawasaki Medical School, 2-1-80 Nakasange, Kita-ku, Okayama 700-8505, Japan.Department of General Internal Medicine 1, Kawasaki Medical School2-1-80 NakasangeKita-ku, Okayama 700-8505Japan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Keywords : Diabetic ketoacidosis, Plasma procalcitonin levels, Type 1 diabetes mellitus
Le texte complet de cet article est disponible en PDF.
Plan
© 2019
Elsevier Masson SAS. Tous droits réservés.
Vol 46 - N° 6
P. 504-505 - novembre 2020 Retour au numéro
Article précédent
- PNPLA3 polymorphism influences the association between high-normal TSH level and NASH in euthyroid adults with biopsy-proven NAFLD
- D.-S. Hu, S.-H. Zhu, W.-Y. Liu, X.-Y. Pan, P.-W. Zhu, Y.-Y. Li, K.I. Zheng, H.-L. Ma, J. You, G. Targher, C.D. Byrne, Y.-P. Chen, M.-H. Zheng
- Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19
- G. Targher, A. Mantovani, C.D. Byrne, X.-B. Wang, H.-D. Yan, Q.-F. Sun, K.-H. Pan, K.I. Zheng, Y.-P. Chen, M. Eslam, J. George, M.-H. Zheng
Bienvenue sur EM-consulte, la référence des professionnels de santé.